{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:32:17Z","timestamp":1768275137612,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Key Technologies R & D program of Tianjin","award":["13ZCZCSY20300"],"award-info":[{"award-number":["13ZCZCSY20300"]}]},{"name":"Science and Technology","award":["20140112"],"award-info":[{"award-number":["20140112"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.leukres.2018.07.020","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T06:48:49Z","timestamp":1532587729000},"page":"5-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A lower ALC\/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified"],"prefix":"10.1016","volume":"73","author":[{"given":"Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanfang","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2018.07.020_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-016-0267-0","article-title":"Therapeutic options in peripheral T cell lymphoma","volume":"9","author":"Zhang","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.critrevonc.2013.08.016","article-title":"Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation","volume":"89","author":"Gkotzamanidou","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0015","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.07.020_bib0020","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Harris","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0025","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.07.020_bib0030","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2010-05-283820","article-title":"Immunosuppressive CD14+ HLA-DR low\/\u2212 monocytes in B-cell non-Hodgkin lymphoma","volume":"117","author":"Lin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.07.020_bib0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","article-title":"Immunodeficiency-associated lymphomas","volume":"22","author":"Tran","year":"2008","journal-title":"Blood Rev."},{"key":"10.1016\/j.leukres.2018.07.020_bib0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2018.07.020_bib0045","first-page":"295","article-title":"Optimal use of prognostic factors in non-Hodgkin lymphoma","volume":"2006","author":"Sehn","year":"2006","journal-title":"ASH Educ. Program Book"},{"key":"10.1016\/j.leukres.2018.07.020_bib0050","first-page":"283","article-title":"Suppressor monocytes in human disease: a review","volume":"121","author":"Schechter","year":"1979","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cncr.23168","article-title":"Absolute lymphocyte count is a novel prognostic indicator in ALL and AML","volume":"112","author":"De Angulo","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2018.07.020_bib0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdq314","article-title":"Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer\/T-cell lymphoma, nasal type","volume":"22","author":"Huang","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0065","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/sj.leu.2404780","article-title":"Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma","volume":"21","author":"Kim","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.07.020_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-8722-4-34","article-title":"Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy","volume":"4","author":"Kim","year":"2011","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0075","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/sj.leu.2404819","article-title":"Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas","volume":"21","author":"Porrata","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2018.07.020_bib0080","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2009-05-220111","article-title":"Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.07.020_bib0085","doi-asserted-by":"crossref","first-page":"e41658","DOI":"10.1371\/journal.pone.0041658","article-title":"Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2018.07.020_bib0090","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2011.050138","article-title":"Peripheral blood lymphocyte\/monocyte ratio at diagnosis and survival in classical Hodgkin\u2019s lymphoma","volume":"97","author":"Porrata","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2018.07.020_bib0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0100","volume":"2008","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.leukres.2018.07.020_bib0105","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2018.07.020_bib0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0115","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/ajh.23566","article-title":"The lymphocyte to monocyte ratio improves the IPI\u2010risk definition of diffuse large B\u2010cell lymphoma when rituximab is added to chemotherapy","volume":"88","author":"Rambaldi","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0120","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2018.07.020_bib0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ijc.25969","article-title":"Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer\/T\u2010cell lymphoma cells by cell contact\u2010dependent interaction through membrane\u2010bound IL\u201015","volume":"130","author":"Ishii","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.leukres.2018.07.020_bib0130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4132\/KoreanJPathol.2013.47.6.526","article-title":"Prognostic significance of absolute lymphocyte count\/absolute monocyte count ratio at diagnosis in patients with multiple myeloma","volume":"47","author":"Shin","year":"2013","journal-title":"Korean J. Pathol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/00313020500370192","article-title":"The epidemiology of non-Hodgkin lymphoma","volume":"37","author":"Grulich","year":"2005","journal-title":"Pathology"},{"key":"10.1016\/j.leukres.2018.07.020_bib0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.semcancer.2011.09.010","article-title":"Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes","author":"Smedby","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.leukres.2018.07.020_bib0145","first-page":"936","article-title":"Lymphoma: risk and response after solid organ transplant","volume":"24","author":"Jacobson","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.leukres.2018.07.020_bib0150","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3109\/10428194.2010.508189","article-title":"Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified","volume":"51","author":"Castillo","year":"2010","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2018.07.020_bib0155","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","article-title":"Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas","volume":"69","author":"Ray-Coquard","year":"2009","journal-title":"Cancer Res."},{"issue":"December 35(36)","key":"10.1016\/j.leukres.2018.07.020_bib0160","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1200\/JCO.2017.73.8195","article-title":"Free survival at 24 months and subsequent survival in peripheral T-Cell lymphoma","volume":"20","author":"Maurer","year":"2017","journal-title":"J. Clin. Oncol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212618301644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T19:04:02Z","timestamp":1538766242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212618301644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":32,"alternative-id":["S0145212618301644"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2018.07.020","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A lower ALC\/AMC ratio is associated with poor prognosis of peripheral T-cell lymphoma-not otherwise specified","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2018.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}